BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33901997)

  • 1. Potential association between elevated serum human epididymis protein 4 and chronic kidney disease in female patients.
    Meng ZJ; Li XJ; Liu F; Li RS; Liang HP
    J Physiol Pharmacol; 2020 Dec; 71(6):. PubMed ID: 33901997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Epididymis Protein 4 as a Potential Biomarker of Chronic Kidney Disease in Female Patients With Normal Ovarian Function.
    Yuan T; Li Y
    Lab Med; 2017 Aug; 48(3):238-243. PubMed ID: 28934517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction.
    Wang L; Sun Y; Cai X; Fu G
    Int Urol Nephrol; 2018 Nov; 50(11):2043-2048. PubMed ID: 30006786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.
    Wan J; Wang Y; Cai G; Liang J; Yue C; Wang F; Song J; Wang J; Liu M; Luo J; Li L
    Oncotarget; 2016 Oct; 7(42):67748-67759. PubMed ID: 27589683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.
    Werner K; Pihlsgård M; Elmståhl S; Legrand H; Nyman U; Christensson A
    Nephron; 2017; 137(1):29-37. PubMed ID: 28407629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.
    Ji F; Zhang S; Jiang X; Xu Y; Chen Z; Fan Y; Wang W
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27726176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Beta 2-Microglobulin, Cystatin C, and Lipocalin-2 as Renal Biomarkers for Patients with Fabry Disease.
    Braga MC; Fonseca FLA; Marins MM; Gomes CP; Bacci MR; Martins AM; D'Almeida V
    Nephron; 2019; 143(4):217-227. PubMed ID: 31216546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
    Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
    J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
    Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
    Front Immunol; 2021; 12():670642. PubMed ID: 34248951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.
    Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Satanovskij R; Angermann S; Hasenau AL; Stecher L; Heemann U; Renders L; Scherberich J
    Medicine (Baltimore); 2016 Mar; 95(10):e3011. PubMed ID: 26962815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the Upper Reference Limit of Human Epididymis Secretory Protein 4 (HE4) in Healthy Male Individuals and Correlation with Renal and Fertility Markers.
    Schirinzi A; Cazzolla AP; Mascolo E; Palmieri G; Pesce F; Gesualdo L; Santacroce L; Ballini A; Lovero R; Di Serio F
    Endocr Metab Immune Disord Drug Targets; 2021; 21(5):912-918. PubMed ID: 32767951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes.
    Suzuki Y; Matsushita K; Seimiya M; Yoshida T; Sawabe Y; Ogawa M; Nomura F
    Clin Chem Lab Med; 2012 Oct; 50(10):1833-9. PubMed ID: 23089714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Epididymis Protein 4 as an Indicator of Acute Heart Failure in Patients with Chronic Kidney Disease.
    Huang Y; Jiang H; Zhu L
    Lab Med; 2020 Mar; 51(2):169-175. PubMed ID: 31245814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of serum human epididymis protein 4 (HE4) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) as predicting factors for the occurrence of acute kidney injury on chronic kidney disease: a single-center retrospective self-control study.
    Song J; Chen L; Yuan Z; Gong X
    Front Pharmacol; 2023; 14():1269311. PubMed ID: 37753112
    [No Abstract]   [Full Text] [Related]  

  • 16. Cystatin C provides a better estimate of the effect of glomerular filtration rate on serum human epididymis protein 4 concentrations.
    Ferraro S; Pasqualetti S; Carnevale A; Panteghini M
    Clin Chem Lab Med; 2016 Oct; 54(10):1629-34. PubMed ID: 27092650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
    Foster MC; Levey AS; Inker LA; Shafi T; Fan L; Gudnason V; Katz R; Mitchell GF; Okparavero A; Palsson R; Post WS; Shlipak MG
    Am J Kidney Dis; 2017 Sep; 70(3):406-414. PubMed ID: 28549536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M; Zhao B; Xie J; Liang Y; Yang Z
    Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Variability of Estimated GFR and Albuminuria in CKD.
    Waikar SS; Rebholz CM; Zheng Z; Hurwitz S; Hsu CY; Feldman HI; Xie D; Liu KD; Mifflin TE; Eckfeldt JH; Kimmel PL; Vasan RS; Bonventre JV; Inker LA; Coresh J;
    Am J Kidney Dis; 2018 Oct; 72(4):538-546. PubMed ID: 30031564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
    Sinna MM; Altaf FMN; Mosa OF
    Curr Pharm Des; 2019; 25(10):1122-1133. PubMed ID: 31096894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.